Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
Contact your MP or a Member of the House of Lords about an issue that matters to you
Sign up for the Your Parliament newsletter to find out how you can get involved
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Follow this EDM by:
That this House notes with concern the withdrawal of public funding from the Fetal Anti-Convulsant Litigation in November 2010; further notes that the taxpayer is now covering the additional health, education and welfare costs incurred by families affected by fetal valproate syndrome; believes the Department of Health and the Medicines and Healthcare products Regulatory Agency could have avoided the large numbers of people affected, since the drug sodium valproate came onto the market in the late 1970s, by informing patients treated with anti-convulsant medications and women of child-bearing age; and calls for an independent inquiry into why information has been withheld from the public concerning the disastrous way in which sodium valproate has affected pregnant women and their children.
Total number of signatures: 33
Showing 33 out of 33